CompuGroup Medical
Synchronizing Healthcare

Find out everything about the vision, mission, and the people who shape CompuGroup Medical worldwide. Investors will also find helpful information, documents, and other publications.

About Us
Careers
Press Releases

MolDX, Medicare MAC, and Z-Code Identifiers: What every lab needs to know

April 22, 2026 | Tami Shaw
Scientists performing molecular testing in the lab.

If you perform molecular diagnostic testing, the MoIDX program isn't something you can afford to overlook.

What began as a regional Medicare requirement has grown into a broad industry standard—and payers are expanding their requirements faster than many labs realize. Understanding how MoIDX, Medicare Administrative Contractors (MACs), and Z-Code® Identifiers work together is now essential to getting paid accurately and avoiding costly claim denials.

Here's a practical breakdown of each component, who needs to participate, and how to get started.

What is the MolDX program?

MoIDX—short for Molecular Diagnostics—is a program governed by Palmetto GBA, one of seven Medicare Administrative Contractors operating across the United States. The program emerged around 2010 in response to the rapid growth of molecular testing, at a time when payers were struggling to assess the clinical utility of these tests and build coherent billing policies around them.

The core purpose of MoIDX is straightforward: to document evidence that molecular tests billed to Medicare are analytically valid and clinically useful. Think of it like vehicle registration. Just as registering a car ties a specific vehicle to a specific owner, MoIDX ties a specific test—performed using specific equipment, methodology, and targets—to the laboratory performing it.

This distinction matters because a UTI panel from one lab is not necessarily the same as a UTI panel from another. By creating a registry and assigning unique test identifiers (Z-Codes), MoIDX helps enforce coding and billing accuracy and reduces miscoding, duplicate billing, and fraud and abuse.

Who needs to participate?

Originally, MoIDX participation was required only by five of the seven MACs. If your lab happened to fall under one of the two non-participating MACs, you could largely ignore it. That is no longer the case.

Today, anyone performing molecular testing should register with the DEX Exchange. A growing list of commercial payers now require the Z-Code Identifier on claims, including:

  • UnitedHealthcare (UHC)
  • Humana
  • OptumCare
  • United Healthcare Community Plans (Medicaid)
  • Medical Mutual of Ohio
  • Fallon Health
  • Blue Cross Blue Shield of North Carolina
  • Community Health Plan of Washington
  • MVP Healthcare

That list continues to grow. Even if you're in a MAC jurisdiction that hasn't historically participated in MoIDX, you now need a DEX Exchange account and registered Z-Codes to bill these commercial payers correctly.

Understanding Medicare MACs: Your regional Medicare authority

Medicare Administrative Contractors are private companies that administer Medicare Part A and Part B claims on behalf of Medicare within specific geographic jurisdictions. There are seven MACs in the United States:

  • First Coast Service Options
  • CGS Administrators
  • NGS Medicare
  • Noridian Healthcare Solutions
  • Novitas Solutions
  • Palmetto GBA
  • WPS Government Health Administrators

Each MAC is responsible for processing and paying claims, enrolling providers, educating providers, and conducting medical reviews and audits. They also issue Local Coverage Determinations (LCDs)—specific billing guidance that supplements national Medicare policy.

It's worth noting that some MACs cover multiple jurisdictions with slightly different policies, so understanding your specific MAC and jurisdiction is important for compliance.

The DEX Exchange: Your gateway to MolDX registration

The Diagnostic Exchange (DEX Exchange) is a secure portal that collects and manages information about molecular test coverage, coding, and utilization oversight. It is the operational hub of the MoIDX program.

The DEX Exchange serves several key functions:

  • Registers and catalogs molecular diagnostic tests by lab or manufacturer
  • Enables standardized review and tracking of test utilization
  • Documents the evidence used to determine medical necessity and coverage policies
  • Supports prior authorization and claim adjudication for Medicare contractors and payers
  • Improves transparency and consistency in billing, coding, and payment

Anyone can register for a free, public user account to explore available information. Labs and manufacturers can register their tests through the DEX Exchange Registration Portal, too, though each lab account allows only two users—so choose wisely. Ideally, one user should be from operations and one from billing, since this is exactly where those two functions intersect.

How Z-Code Identifiers work

Once you've registered your test with the DEX Exchange, here is what to expect:

Step 1: Z-Code assignment (within ~2 weeks)

After submitting your initial test registration, you'll receive a Z-Code Identifier within approximately two weeks. This does not mean you've been approved for coverage—it simply links your specific test to your laboratory.

Step 2: Technical assessment

Be ready. Almost universally, labs are asked to complete a Technical Assessment within 14 days of receiving their Z-Code. This is a thorough review requiring documentation of:

  • Analytical validity: Is the test accurate and consistent?
  • Clinical validity: Has the test been thoroughly vetted?
  • Clinical utility: How will the test be used to guide patient care?
  • Peer-reviewed publications supporting the test methodology

Your Z-Code is not effective for reimbursement until this Technical Assessment process is complete and approved.

Step 3: CPT® code assignment and approved reimbursement

Once approved, the DEX Exchange will assign the specific CPT code you should use for your test. From that point forward, your claim should include your Z-Code Identifier paired with the DEX Exchange-assigned CPT code. This combination unlocks the pre-approved reimbursement rate.

Important: Do not select your own CPT codes after receiving a Z-Code. Follow the DEX Exchange's guidance precisely. Using individually broken-out pathogen CPT codes when the DEX Exchange has assigned a panel code—or vice versa—can result in denied claims and compliance risk.

The benefits of getting registered

While the process can feel burdensome at first, the benefits to your laboratory are significant:

  • Clearer coverage: Pre-qualified approval eliminates guesswork
  • Faster payment: Fewer denials, less rework, quicker reimbursement
  • Reduced denials: Stop chasing appeals with progress notes and medical records
  • Locked-in reimbursement: Approved rates are defined and predictable
  • Marketable credibility: Demonstrate the validity and utility of your tests to potential clients
  • Audit readiness: Documented evidence of clinical validity and utility reduces compliance risk

Why expert billing matters more than ever

Molecular diagnostics is one of the most complex areas in laboratory billing. Specialized CPT and HCPCS codes, modifier rules, payer-specific policies, prior authorization requirements, and evolving MAC guidance make this a space where expertise directly translates to revenue.

The growth of this space has been dramatic. The COVID-19 pandemic pushed many toxicology labs into molecular testing almost overnight. When COVID testing volumes declined, many of those labs pivoted to infectious disease—which continues to grow rapidly. That growth is exactly why payers are taking notice and why MoIDX participation is becoming universal.

For labs managing this in-house, the learning curve is steep. Knowledgeable billers who understand this space can ensure correct test ordering, maximize appropriate reimbursement, avoid denials, reduce costly rework, and keep your practice compliant with current guidelines. They can also manage prior authorizations and support appeals when claims are denied—ensuring your laboratory captures full, timely payment for high-cost molecular services.

Increase revenue velocity with help from the experts

Winner of the 2024, 2025 and 2026 Best in KLAS award for ambulatory RCM services (EHR-Associated), ARIA partners with practices and labs to deliver expert medical billing services.

Need help navigating MolDX and molecular billing?

ARIA RCM Services offers specialized revenue cycle management for laboratories, including molecular billing expertise.

Whether you need a full billing solution or targeted support with specific challenges like aging AR, prior authorizations, or MoIDX registration guidance, our team acts as an extension of yours.

Request a free billing analysis to see how ARIA RCM Services can help your laboratory get paid faster and more accurately.

Related Articles
ARIA RCM Services wins Best in KLAS
Maximizing revenue: Aging AR services for labs
Inefficient accounts receivable management can ...
Research scientist uses a micro pipette
Simplify PCR testing by leveraging your LIS

Polymerase chain reaction (PCR) testing has become a cornerstone of ...